Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 12 Carcinoma, Hepatocellular 7 Neoplasm Metastasis 5 Colorectal Neoplasms 5 Esophageal Squamous Cell Carcinoma 4 Advanced Solid Tumor 4 Solid Tumor 3 Small Cell Lung Carcinoma 3 Lung Neoplasms 3 Esophageal Neoplasms 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Rectal Neoplasms 2 Melanoma 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Advanced Solid Tumour 2 Unresectable Stage III Non-small Cell Lung Cancer 1 Triple Negative Breast Neoplasms 1 Skin Neoplasms 1 Simpson-Golabi-Behmel syndrome 1 Patients With Initially Unresectable MSS-type Advanced Colorectal Cancer With Liver and/or Lung and Peritoneal Metastasis 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Nasopharyngeal Carcinoma 1 Metastatic Solid Tumors 1

Interventions

Cyclophosphamide 18 fludarabine phosphate 12 pembrolizumab 11 Nivolumab 11 Brentuximab Vedotin 11 Mycophenolic Acid 10 Doxorubicin 10 fludarabine 9 Dacarbazine 9 Whole-Body Irradiation 8 Etoposide 8 Vinblastine 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 Filgrastim 7 Cyclosporine 7 Granulocyte Colony-Stimulating Factor 6 Sirolimus 5 Radiotherapy 5 Peripheral Blood Stem Cell Transplantation 5 Melphalan 5 Gemcitabine 5 Busulfan 5 Tacrolimus 4 pegfilgrastim 3 Vinorelbine 3 Stem Cell Transplantation 3 Rituximab 3 Radiation 3 Prednisone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hodgkin Disease × tislelizumab × 90 days × Clear all

NCT05502250 2026-03-06

HOVON164HL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 2 Active not recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡